the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate)

You'll hear about the second ORAL drug for relapsing-remitting multiple sclerosis (MS), Tecfidera (TEK-fi-de-rah, dimethyl fumarate).

Think of it as a form of fumaric acid. It's a new therapy for MS...but has been used for years in Europe for psoriasis.

Tecfidera seems to protect neurons and myelin, and have anti-inflammatory effects. It seems to work about as well as Gilenya (fingolimod)...with fewer serious risks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote